PET is Wonderful Annual Meeting 2021 Oct 26, 2021 12:00 AM — Virtual Meeting (online)
NRS Mental Health Network Annual Scientific Meeting 2021 Nov 02, 2021 09:00 AM - 05:00 PM — Royal College of Physicians, Edinburgh (and online)
SRS Autumn Meeting 2021 Nov 12, 2021 08:30 AM - 04:00 PM — Dundee


SINAPSE experts from around Scotland have developed ten online modules designed to explain medical imaging. They are freely available and are intended for non-specialists.

Edinburgh Imaging Academy at the University of Edinburgh offers the following online programmes through a virtual learning environment:

Neuroimaging for Research MSc/Dip/Cert

Imaging MSc/Dip/Cert

PET-MR Principles & Applications Cert

Applied Medical Image Analysis Cert

Online Short Courses

5alpha-reductase type 1 modulates insulin sensitivity in men

Author(s): R. Upreti, K. A. Hughes, D. E. Livingstone, C. D. Gray, F. C. Minns, D. P. Macfarlane, I. Marshall, L. H. Stewart, B. R. Walker, R. Andrew

CONTEXT: 5alpha-Reductase (5alphaR) types 1 and 2 catalyze the A-ring reduction of steroids, including androgens and glucocorticoids. 5alpha-R inhibitors lower dihydrotestosterone in benign prostatic hyperplasia; finasteride inhibits 5alphaR2, and dutasteride inhibits both 5alphaR2 and 5alphaR1. In rodents, loss of 5alphaR1 promotes fatty liver. OBJECTIVE: Our objective was to test the hypothesis that inhibition of 5alphaR1 causes metabolic dysfunction in humans. DESIGN, SETTING, AND PARTICIPANTS: This double-blind randomized controlled parallel group study at a clinical research facility included 46 men (20-85 years) studied before and after intervention. INTERVENTION: Oral dutasteride (0.5 mg daily; n = 16), finasteride (5 mg daily; n = 16), or control (tamsulosin; 0.4 mg daily; n = 14) was administered for 3 months. MAIN OUTCOME MEASURE: Glucose disposal was measured during a stepwise hyperinsulinemic-euglycemic clamp. Data are mean (SEM). RESULTS: Dutasteride and finasteride had similar effects on steroid profiles, with reduced urinary androgen and glucocorticoid metabolites and reduced circulating DHT but no change in plasma or salivary cortisol. Dutasteride, but not finasteride, reduced stimulation of glucose disposal by high-dose insulin (dutasteride by -5.7 [3.2] mumol/kg fat-free mass/min, versus finasteride +7.2 [3.0], and tamsulosin +7.0 [2.0]). Dutasteride also reduced suppression of nonesterified fatty acids by insulin and increased body fat (by 1.6% [0.6%]). Glucose production and glycerol turnover were unchanged. Consistent with metabolic effects of dutasteride being mediated in peripheral tissues, mRNA for 5alphaR1 but not 5alphaR2 was detected in human adipose tissue. CONCLUSION: Dual inhibition of 5alphaRs, but not inhibition of 5alphaR2 alone, modulates insulin sensitivity in human peripheral tissues rather than liver. This may have important implications for patients prescribed dutasteride for prostatic disease.

Full version: Available here

Click the link to go to an external website with the full version of the paper

ISBN: 1945-7197 (Electronic) 0021-972X (Linking)
Publication Year: 2014
Periodical: J Clin Endocrinol Metab
Periodical Number: 8
Volume: 99
Pages: E1397-406
Author Address: University/British Heart Foundation Centre for Cardiovascular Science (R.U., K.A.H., D.E.W.L., D.P.M., I.M., B.R.W., R.A.) and Clinical Research Imaging Centre (C.D.G.), University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, United Kingdom; and Radiology (F.C.M.) and Urology (L.H.S.) Departments, National Health Service Lothian University Hospitals Division, Western General Hospital, Edinburgh EH4 2XU, United Kingdom.